DOI:10.2214/AJR.07.2724
AJR 2008; 190:158-164
© American Roentgen Ray Society
Benign Renal Neoplasms in Adults: Cross-Sectional Imaging Findings
Srinivasa R. Prasad1,
Venkateswar R. Surabhi1,
Christine O. Menias2,
Abhijit A. Raut3 and
Kedar N. Chintapalli1
1 Department of Radiology, University of Texas Health Science Center at San
Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229.
2 Department of Radiology, Mallinckrodt Institute of Radiology, St. Louis,
MO.
3 Department of Radiology, King Edward Memorial Hospital, Mumbai, India.
Received June 13, 2007;
accepted after revision July 16, 2007.
CME This article is available for CME credit. See
www.arrs.org
for more information.
FOR YOUR INFORMATION
This article is available for CME credit. See
www.arrs.org
for more information.
Address correspondence to S. R. Prasad
(prasads{at}uthscsa.edu).
Abstract
OBJECTIVE. A broad spectrum of benign renal neoplasms in adults
shows characteristic ontogeny, histology, and tumor biology. Benign renal
tumors are classified into renal cell tumors, metanephric tumors, mesenchymal
tumors, and mixed epithelial and mesenchymal tumors. Select benign tumors show
characteristic anatomic distribution and imaging features. However, because of
overlapping of findings between benign and malignant renal tumors, histologic
evaluation may be required to establish a definitive diagnosis. Accurate
preoperative characterization facilitates optimal patient management.
CONCLUSION. We attempt to provide a comprehensive, contemporary
review of benign renal neoplasms that occur in adults, focusing on
cross-sectional imaging characteristics.
Keywords: benign tumors CT kidney MRI renal neoplasms sonography
Introduction
Benign renal neoplasms that occur in adults constitute a
heterogeneous group of tumors with characteristic histology and variable
clinicobiologic profiles. The 2004 World Health Organization (WHO)
classification schemata categorizes benign renal neoplasms on the basis of
histogenesis (cell of origin) and histopathology
[1]
(Appendix 1). Renal neoplasms
are thus classified into renal cell, metanephric, mesenchymal, and mixed
epithelial and mesenchymal tumors.
APPENDIX 1: World Health Organization (WHO) Histological Classification of Benign
Renal Neoplasms
Renal Cell Tumors |
Metanephric Tumors |
Mesenchymal Tumors |
Mixed Epithelial and Mesenchymal Tumors |
| Oncocytoma |
Metanephric adenoma |
Angiomyolipoma |
Cystic nephroma |
| Papillary adenoma |
Metanephric adenofibroma |
Leiomyoma |
Mixed epithelial and stromal tumor |
|
Metanephric stromal tumor |
Hemangioma |
|
|
|
Lymphangioma |
|
|
|
Reninoma |
|
|
|
Fibroma |
|
|
|
Schwannoma |
|
|
Recent advances in imaging technology have resulted in the detection of
incidental renal masses in seemingly asymptomatic patients. Although renal
cell carcinoma (RCC) is by far the most lethal urologic malignancy, benign
tumors constitute a significant proportion of masses in patients who undergo
surgery. In a recent study of 143 patients with presumed solitary RCC, the
authors found 16.1% of patients who underwent partial nephrectomy had benign
masses [2]. Other studies have
also found that a significant proportion of solid renal masses are
histologically benign
[3-5].
Also, percutaneous renal mass biopsy is being increasingly performed to
preoperatively characterize renal masses and to establish definitive diagnoses
[3,
4,
6,
7]. Recent advances in
histopathology, immunocytochemistry, and cytogenetics assist in fairly
accurate characterization of most renal masses and help guide optimal patient
management [1,
7,
8]. A recent study of 66 renal
mass biopsies found 98% accuracy and 79% sample adequacy
[7]. However, pathologists
advise caution when interpreting tumors, specifically those with oncocytic
features or hybrid or collision tumors
[7,
9]. Laparoscopic partial
nephrectomies and percutaneous ablations are being increasingly performed to
treat small renal tumors and to establish a definitive diagnosis
[10,
11].
Renal Cell Neoplasms
Oncocytoma
Oncocytoma is a benign renal cell neoplasm that accounts for approximately
5% of all adult primary renal epithelial neoplasms in surgical series
[1]. Oncocytoma is hypothesized
to originate from or differentiate toward type A intercalated cells of the
cortical collecting duct [12,
13]. The peak age of incidence
is in the seventh decade; men are more likely to be affected than women. Most
tumors occur sporadically in asymptomatic patients.
Oncocytoma is histologically composed of nests and acini of large polygonal
cells with mitochondria-rich eosinophilic cytoplasm
[1]. Oncocytomas do not show
diffuse cytoplasmic Hale colloidal iron staining, in contradistinction to
chromophobe RCCs.
Oncocytomas typically appear as solitary, well-demarcated, unencapsulated,
fairly homogeneous renal cortical tumors. Bilateral, multicentric oncocytomas
are seen in hereditary syndromes of renal oncocytosis and
Birt-Hogg-Dubé syndrome (in association with the chromophobe subtype
and other RCC subtypes) [14]
(Fig. 1). A characteristic
central stellate fibrotic scar (more often seen with large tumors) is seen in
up to 33% of tumors [1] (Fig.
2A,
2B). Hemorrhage may be found in
up to 20% of cases. A spoke-wheel pattern of feeding arteries associated with
a homogeneous nephrogram is a characteristic finding on catheter angiography
[15]. However, oncocytomas are
indistinguishable from renal cell carcinomas on the basis of imaging findings
alone. In addition, oncocytomas may be associated with RCCs either as hybrid
tumors (pathologic features of both oncocytomas and chromophobe or other RCC
subtypes) or as collision tumors
[9]. Thus, despite advances in
histopathologic techniques (including immunocytochemistry and cytogenetics), a
partial nephrectomy may be required for accurate characterization
[7].

View larger version (117K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1 —72-year-old man with hereditary oncocytosis syndrome. Coronal
contrast-enhanced CT scan during nephrographic phase shows bilateral solid
renal masses (arrows) that were characterized as oncocytomas on
histopathology.
|
|

View larger version (89K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2A —64-year-old man with histologically proven oncocytoma. K = kidney.
Axial fat-saturated, T2-weighted gradient-refocused echo image shows
expansile, solid right renal mass (arrow) with hyperintense central
scar (S).
|
|

View larger version (118K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2B —64-year-old man with histologically proven oncocytoma. K = kidney.
Axial fat-saturated, gadolinium-enhanced T1-weighted 3D gradient-refocused
echo image shows right kidney mass (arrow) with hypointense central
scar (S).
|
|
Papillary Adenoma
Papillary adenomas are the most common renal epithelial neoplasms.
According to autopsy series, approximately 40% of patients older than 70 years
harbor renal adenomas [1].
Papillary adenomas are also commonly found in patients with acquired renal
cystic disease and in patients undergoing long-term hemodialysis
[16]. A papillary
adenoma-to-carcinoma sequence has been described that is akin to similar
transformation in colonic adenomas
[17,
18].
By definition, papillary adenomas measure 5 mm or less
[1]. They are usually
subcapsular and solitary. Adenomas are histologically characterized by
papillary or tubular cytoar-chitecture and frequent psammoma bodies
[1]. Cytogenetic changes of
papillary adenomas include loss of the Y chromosome and combined trisomy of
chromosomes 7 and 17 [19].
Histologic and genetic abnormalities of renal adenomas are indistinguishable
from papillary RCCs [1,
20].
Papillary adenomas are extremely small (< 5 mm) and may not be
distinguished from other renal tumors (particularly RCC) and pseudotumors on
imaging studies.
Metanephric Neoplasms
Metanephric neoplasms are a heterogeneous group of benign renal neoplasms
that include metanephric adenoma (epithelial tumor), metanephric stromal tumor
(stromal neoplasm), and metanephric adenofibroma (mixed epithelial and stromal
neoplasm) [21]. These tumors
are histogenetically related to Wilms' tumor and are postulated to represent
the most hyperdifferentiated, benign end of the nephroblastoma spectrum
[21]. Metanephric
adenofibromas and metanephric stromal tumors are essentially pediatric tumors
and will not be discussed in this article.
Metanephric adenoma is a benign renal neoplasm with peak age of occurrence
in the fifth or sixth decade and a 2:1 female preponderance
[1]. Metanephric adenoma is
asymptomatic in approximately 50% of patients; abdominal pain and hematuria
are common clinical symptoms. Polycythemia, a characteristic finding seen in
approximately 10% of patients with metanephric adenoma, promptly disappears
after surgical resection
[22].
Metanephric adenoma is histologically characterized by the arrangement of
monotonous small blue embryonal epithelial cells in an acinar, tubular, or
sheetlike configuration [21].
Abundant psammoma bodies are commonly found.
Metanephric adenoma typically appears as a well-defined, unencapsulated,
solitary solid mass [21,
22]
(Fig. 3). It commonly appears
as a hyperattenuating mass on unenhanced CT; large tumors appear as
heterogeneous, hypovascular masses with frequent foci of hemorrhage and
necrosis [23,
24]. Calcification is seen in
20% of cases. Metanephric adenoma shows a hypointense signal on T1-weighted
MRI and a slightly hyperintense signal on T2-weighted MRI
[25]. Metanephric adenoma
appears as an expansile hypoechoic or hyperechoic mass on sonography. True
cystic forms of metanephric adenoma are rare
[26].

View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3 —Contrast-enhanced axial CT scan in 60-year-old woman with hematuria
shows hypoattenuating, expansile solid mass (arrows) in left kidney.
Radical nephrectomy showed mass to be metanephric adenoma. K = kidney.
|
|
Mesenchymal Neoplasms
Angiomyolipoma
Angiomyolipoma (AML) is the most common benign mesenchymal neoplasm; it is
composed of variable proportions of blood vessels, smooth muscle, and adipose
tissue [1]. AMLs are now
included under the umbrella term "neoplasms of the perivascular
epithelioid cells," which are also referred to as PEComas
[27]. Renal AMLs consist of
two distinct histologic subtypes, classic triphasic and monotypic epithelioid.
Epithelioid AMLs typically do not show macroscopic fat and appear as
soft-tissue masses and are thus indistinguishable from other solid renal
masses. This rare subtype of AML is potentially malignant and may exhibit
aggressive biology, including recurrence, metastasis, and death. It will not
be further discussed in this article
[27,
28].
Classic AML may occur either sporadically or in association with tuberous
sclerosis complex (TSC). Sporadic renal AMLs show a 4:1 female preponderance
and are more likely to be solitary and symptomatic
[29]. Patients with TSC harbor
small, multicentric, asymptomatic AMLs; 80% of patients with severe TSC have
renal AMLs [30]. The
morphology of AMLs depends on the relative proportions of various components.
Profuse elastin-poor, dysmorphic blood vessels predispose to aneurysm
formation and hemorrhage [29].
Large tumor size (> 4 cm) and diameter of the intralesional aneurysms (>
5 mm) correlate directly with tumor-related hemorrhage in AMLs
[31].

View larger version (115K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6A —38-year-old woman with documented tuberous sclerosis complex and
renal angiomyolipomas. Axial in-phase T1-weighted 2D gradient-refocused echo
MR image shows bilateral multicentric renal masses that have increased signal
intensity (arrows).
|
|

View larger version (107K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6B —38-year-old woman with documented tuberous sclerosis complex and
renal angiomyolipomas. Axial fat-saturated T2-weighted 2D gradient-refocused
echo MR image shows marked drop in signal intensity of masses
(arrows).
|
|

View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7 —55-year-old woman who underwent partial nephrectomy for
serendipitously detected renal mass. Axial contrast-enhanced CT scan shows
exophytic soft-tissue mass (arrow). Histopathology showed lipid-poor
angiomyolipoma.
|
|
On sonography, small AMLs appear uniformly hyperechoic without a hypoechoic
rim or intralesional cysts
[32]
(Fig. 4). Large AMLs appear as
variegated masses with macroscopic fat, hemorrhage, and hypervascular
soft-tissue components. Intralesional aneurysms are seen in large tumors as
well. The presence of macroscopic fat on CT or MRI is characteristic of AMLs
(Fig. 5). Loss of signal
intensity on frequency-selective fat-suppressed MRI definitively identifies
macroscopic fat [30] (Fig.
6A,
6B). However, a multitude of
renal neoplasms, including RCC, oncocytoma, lipoma, and liposarcoma, may show
either intratumoral fat or engulfed perirenal fat
[33]. Approximately 4.5% of
AMLs may not show identifiable macroscopic fat and are indistinguishable from
RCC on imaging studies alone (Fig.
7). Recent studies indicate that in contradistinction to RCCs,
AMLs with minimal fat show uniform, prolonged contrast enhancement and a
higher signal intensity index on double-echo, chemical shift FLASH MRI
[34,
35].
Hemangioma
Renal hemangioma is a rare benign mesenchymal neoplasm that consists of
multiple endothelium-lined, blood-filled vascular spaces
[1]. It commonly affects young
adults with no specific sex predilection. Recurrent episodes of hematuria and
renal colic are typical presenting symptoms; however, incidental diagnosis in
asymptomatic patients is also common
[36]. Hemangiomas of the
kidney may be associated with systemic syndromes such as Sturge-Weber and
Klippel-Trénaunay and with systemic angiomatosis
[1]. Cavernous hemangiomas are
more common than the capillary variants.
Hemangioma of the kidney occurs as an unencapsulated, unicentric, solitary
tumor that frequently arises from the renal pyramids or the pelvis
[1,
37]. Hemangiomas show variable
echogenicity on sonography and hyperintensity on T2-weighted MRI
[38]
(Fig. 8A). Contrast-enhanced
CT and MRI of renal hemangiomas may show early, intense enhancement
(Fig. 8B). Persistent contrast
enhancement on delayed images is fairly characteristic of renal hemangiomas
[37].

View larger version (118K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 8A —60-year-old man with hematuria and histologically proven hemangioma.
Axial fat-saturated T2-weighted 2D gradient-refocused echo MR image shows
hyperintense left kidney mass in renal sinus (arrow).
|
|

View larger version (129K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 8B —60-year-old man with hematuria and histologically proven hemangioma.
Axial fat-saturated gadolinium-enhanced T1-weighted 3D gradient-refocused echo
MR image shows contrast enhancement of left renal sinus mass
(arrows).
|
|
Lymphangioma
Lymphangioma of the kidney is a rare benign cystic tumor that most often
arises from the peripelvic region or renal sinus
[1]. It may also uncommonly
arise from the lymphatics of the capsule or the cortex
[39]. Histologically,
lymphangiomas consist of communicating endothelium-lined spaces that contain
clear fluid [1]. The septa may
show lymphoid cells.

View larger version (119K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 9 —47-year-old man with bilateral multiple renal sinuses and
perinephric lymphangiomatosis. Unenhanced axial CT scan shows multicentric
cystic masses in renal sinus and perinephric spaces (arrows).
|
|

View larger version (117K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 11 —23-year-old woman with hypertension refractory to standard
treatment. Axial unenhanced CT scan shows large, expansile right renal mass
(arrow) that was histologically proven to be juxtaglomerular cell
neoplasm (reninoma). K = kidney, M = mass.
|
|
Renal lymphangioma may occur either as an isolated finding or in
association with perinephric or systemic lymphangiomatosis
[39]. It may appear as a
localized process or a diffusely cystic lesion. Lymphangioma typically appears
as a well-demarcated, uni- or multilocular cystic neoplasm that most commonly
arises from the renal sinus region or in the perinephric space
[40,
41]
(Fig. 9).
Leiomyoma
Renal leiomyomas are rare benign smooth-muscle neoplasms that mostly occur
in adults as incidental findings
[1]. Renal capsule is the most
common target site of leiomyomas; rarely, leiomyomas originate from the renal
pelvis or cortex. Intersecting fascicles of spindle cells that show
immunoreactivity to actin or desmin (smooth-muscle markers) are characteristic
histologic features [1].
Leiomyomas of the kidney commonly appear as well-circumscribed,
homogeneous, exophytic solid masses that show uniform enhancement on
contrast-enhanced CT [42]
(Fig. 10). Larger tumors are
heterogeneous because of hemorrhage and cystic or myxoid degeneration
[43,
44]. Calcification is
uncommon. However, the CT findings of leiomyomas of the kidney may be variable
and may include cystic, complex cystic-solid, or purely solid morphology
[44]. Renal leiomyomas may
show hypervascularity on catheter angiography because they are predominantly
supplied by capsular vessels
[42,
45].
Juxtaglomerular Cell Neoplasm (Reninoma)
Juxtaglomerular cell (JGC) neoplasm is an extremely rare, benign renal
neoplasm of myoendocrine cell origin
[46]. The peak age of
incidence is in the second and third decades and a 2:1 female preponderance is
seen. JGC neoplasm is clinically characterized by a triad of findings: poorly
controlled hypertension, hypokalemia, and high plasma renin activity
[47]. Histologically, JGC
neoplasm consists of sheets of polygonal or spindle cells and a
characteristic, complex, hemangiopericytic angioarchitecture
[1]. The presence of rhom-boid
renin protogranules is diagnostic of JGC neoplasm
[46].
JGC neoplasm typically appears as a unilateral, well-circumscribed,
cortical tumor that usually measures less than 3 cm
[13]
(Fig. 11). Despite profuse
vascularity, JGC neoplasms appear hypovascular on contrast-enhanced CT and
MRI, possibly because of renin-induced vasoconstriction
[48,
49]. JGC neoplasms may show
delayed contrast enhancement. Imaging findings of JGC neoplasms are
nonspecific and indistinguishable from other solid renal neoplasms.

View larger version (130K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 13 —40-year-old woman with histologically proven mixed epithelial and
stromal tumor of kidney. Axial contrast-enhanced CT scan shows large complex
cystic left kidney (K) mass (arrows) with septations and solid
components.
|
|
Renomedullary Interstitial Cell Tumor
Also referred to as medullary fibromas, renomedullary interstitial cell
tumors are benign neoplasms that arise from renomedullary interstitial cells,
small stellate cells that are thought to play a role in blood pressure
homeostasis [50].
Renomedullary interstitial cell tumors are common incidental findings that are
present in 50% of adults in autopsy series
[1].
Most renomedullary interstitial cell tumors are small and typically measure
less than 5 mm. The renal pyramid is the characteristic location of
renomedullary interstitial cell tumors
[1]. Rarely, large
renomedullary interstitial cell tumors extend into the renal pelvis. They
appear as nonenhancing, hypoattenuating renal medullary solid lesions without
calcification (Fig. 12).
Mixed Epithelial and Mesenchymal Neoplasms
Mixed epithelial and mesenchymal neoplasms comprise two histologically
distinct entities: mixed epithelial and stromal tumors and cystic nephromas.
However, recent studies have found remarkable demographic, clinical, and
pathologic similarities among these entities and a new name, renal epithelial
and stromal tumor, has been proposed
[51,
52]. This nomenclature is
still new and has yet to be universally accepted; we will discuss these two
entities separately in this article according to WHO taxonomic schemata.
Mixed Epithelial and Stromal Tumor
The entity mixed epithelial and stromal tumor was previously called by
several descriptive names reflecting variegated tumor histology. It is now
thought that mixed epithelial and stromal tumor was previously referred to as
leiomyomatous renal hamartoma, multilocular cyst with ovarian stroma, cystic
hamartoma of the renal pelvis, and adult mesoblastic nephroma
[53-55].
The unifying term, mixed epithelial and stromal tumor, was first coined by
Michal and Syrucek in 1998
[56]; two recent large series
have largely contributed to our understanding of mixed epithelial and stromal
tumors [57,
58].
Mixed epithelial and stromal tumors occur almost exclusively in
perimenopausal women (6:1 female preponderance); most patients are receiving
estrogen therapy [57,
58]. Twenty-five percent of
the tumors present as incidental findings; most patients manifest nonspecific
symptoms of flank pain and hematuria. Pathologically, mixed epithelial and
stromal tumor is a benign, bimorphic solid-cystic neoplasm that consists of
epithelium-lined cysts or microcysts and variably cellular spindle-cell,
ovarianlike (estrogen- or progester-one-receptor positive) stroma
[57,
58].
On imaging, mixed epithelial and stromal tumors typically appear as
expansile, complex, cystic-solid masses with heterogeneous and delayed
enhancement [59]
(Fig. 13). The proportion of
cystic and solid constituents varies in any given case. The stromal component
of the tumor is thought to be responsible for the hypointense signal on
T2-weighted MRI with delayed contrast enhancement
[59]. Large mixed epithelial
and stromal tumors may herniate into the renal pelvis. The tumors typically
show benign biologic behavior without recurrence or metastasis; however,
aggressive mixed epithelial and stromal tumors with sarcomatous transformation
of the stromal component have been described
[60].
Cystic Nephroma
Cystic nephroma is a benign cystic neoplasm that affects predominantly
middle-aged, perimenopausal women
[1]. Adult-onset cystic
nephroma is histogenetically and morphologically different from pediatric
cystic nephroma [39,
61]. Morphologically, cystic
nephromas are composed of encapsulated, noncommunicating cysts with thin
septations. By definition, cystic nephromas are characterized by the absence
of a solid component or necrosis
[1]. On histology, the cysts
are lined by a monolayer of hobnail epithelium; the fibrous septa may be
paucicellular or cellular
[1].
Cystic nephroma appears as a well-demarcated, solitary, multilocular cystic
lesion with thin septations (Fig.
14A). The cystic mass may protrude into the renal pelvis and cause
hemorrhage or urinary obstruction
[62]
(Fig. 14B).
Conclusion
Benign renal tumors that occur in adults cover a wide spectrum and show
characteristic histology, histogenesis, and anatomic distribution. Some benign
tumors of the kidney (such as angiomyolipomas, mixed epithelial and
mesenchymal tumors, leiomyomas, and hemangiomas) show characteristic imaging
findings and regional distribution that permit their diagnosis
(Appendix 2). Although
leiomyomas originate from the renal capsule, hemangiomas typically arise from
the renal sinus. Renomedullary interstitial cell tumors (also known as
medullary fibromas) are commonly confined to the renal medulla. Approximately
one third of large oncocytomas typically show a central stellate scar. Cystic
nephromas show septated cysts, macroscopic fat predominates in most
angiomyolipomas, and metanephric adenomas are commonly solid. Mixed epithelial
and stromal tumors consist of solid areas and cysts that may herniate into the
renal pelvis. However, most benign renal tumors appear as solid enhancing
masses and are thus indistinguishable from the more common malignant renal
neoplasms, notably RCCs. Biopsy of the renal mass may help establish the
definitive diagnosis and may obviate aggressive treatment.
APPENDIX 2: Making Sense of Adult, Benign Renal Neoplasms: A Pattern-Based Imaging
Approach
Soft-Tissue Mass |
Fatty Mass |
Cystic Mass |
Cortical Mass |
Medullary Mass |
| Oncocytoma |
Angiomyolipoma (AML) |
Cystic nephroma |
Leiomyoma |
Hemangioma |
| Lipid-poor AML |
|
Mixed epithelial and stromal tumor |
Oncocytoma |
Fibroma |
| Leiomyoma |
|
Metanephric adenoma (rare) |
AML |
Mixed epithelial and stromal tumor |
| Hemangioma |
|
Lymphangioma |
|
AML |
| Reninoma |
|
|
|
Leiomyoma |
| Fibroma |
|
|
|
|
Schwannoma
|
|
|
|
|
|
References
- Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. World
Health Organization classification of tumors: pathology and genetics of tumors
of the urinary system and male genital organs. Lyon, France: IARC
Press, 2004
- Kutikov A, Fossett LK, Ramchandani P, et al. Incidence of benign
pathologic findings at partial nephrectomy for solitary renal mass presumed to
be renal cell carcinoma on preoperative imaging.
Urology 2006; 68:737
-740[CrossRef][Medline]
- Beland MD, Mayo-Smith WW, Dupuy DE, Cronan JJ, DeLellis RA.
Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal
masses: should we biopsy all that are indeterminate?
AJR 2007; 188:792
-797[Abstract/Free Full Text]
- Maturen KE, Nghiem HV, Caoili EM, Higgins EG, Wolf JS Jr, Wood DP
Jr. Renal mass core biopsy: accuracy and impact on clinical management.
AJR 2007; 188:563
-570[Abstract/Free Full Text]
- Vasudevan A, Davies RJ, Shannon BA, Cohen RJ. Incidental renal
tumours: the frequency of benign lesions and the role of preoperative core
biopsy. BJU Int 2006;97
: 946-949[CrossRef][Medline]
- Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES. Renal masses
in the adult patient: the role of percutaneous biopsy.
Radiology 2006;240
: 6-22[Abstract/Free Full Text]
- Shah RB, Bakshi N, Hafez KS, Wood DP Jr, Kunju LP. Image-guided
biopsy in the evaluation of renal mass lesions in contemporary urological
practice: indications, adequacy, clinical impact, and limitations of the
pathological diagnosis. Hum Pathol 2005;36
: 1309-1315[Medline]
- Jones TD, Eble JN, Cheng L. Application of molecular diagnostic
techniques to renal epithelial neoplasms. Clin Lab Med2005; 25:279
-303[CrossRef][Medline]
- Rowsell C, Fleshner N, Marrano P, Squire J, Evans A. Papillary
renal cell carcinoma within a renal oncocytoma: case report of an incidental
finding of a tumour within a tumour. J Clin Pathol2007; 60:426
-428[Abstract/Free Full Text]
- Venkatesh R, Weld K, Ames CD, et al. Laparoscopic partial
nephrectomy for renal masses: effect of tumor location.
Urology 2006; 67:1169
-1174; discussion 1174[CrossRef][Medline]
- Lotan Y, Duchene DA, Cadeddu JA, Sagalowsky AI, Koeneman KS.
Changing management of organ-confined renal masses. J
Endourol 2004; 18:263
-268[CrossRef][Medline]
- Storkel S, Pannen B, Thoenes W, Steart PV, Wagner S, Drenckhahn D.
Intercalated cells as a probable source for the development of renal
oncocytoma. Virchows Arch B Cell Pathol Incl Mol
Pathol 1988; 56:185
-189[Medline]
- Prasad SR, Narra VR, Shah R, et al. Segmental disorders of the
nephron: histopathological and imaging perspective. Br J
Radiol 2007; 80:593
-602[Abstract/Free Full Text]
- Choyke PL. Imaging of hereditary renal cancer. Radiol
Clin North Am 2003; 41:1037
-1051[CrossRef][Medline]
- Quinn MJ, Hartman DS, Friedman AC, et al. Renal oncocytoma: new
observations. Radiology 1984;153
: 49-53[Abstract/Free Full Text]
- Ishikawa I, Kovacs G. High incidence of papillary renal cell
tumours in patients on chronic haemodialysis.
Histopathology 1993;22
: 135-139[Medline]
- Kiyoshima K, Oda Y, Nakamura T, et al. Multicentric papillary renal
cell carcinoma associated with renal adenomatosis. Pathol
Int 2004; 54:266
-272[CrossRef][Medline]
- Kovacs G. High frequency of papillary renal-cell tumours in
end-stage kidneys: is there a molecular genetic explanation?
Nephrol Dial Transplant 1995;10
: 593-596[Free Full Text]
- Kovacs G, Fuzesi L, Emanual A, Kung HF. Cytogenetics of papillary
renal cell tumors. Genes Chromosomes Cancer1991; 3:249
-255[Medline]
- Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L. Gains of
chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution
of papillary renal cell neoplasia: a fluorescent in situ hybridization study.
Mod Pathol 2003;16
: 1053-1059[CrossRef][Medline]
- Argani P. Metanephric neoplasms: the hyperdifferentiated, benign
end of the Wilms tumor spectrum? Clin Lab Med2005; 25:379
-392[CrossRef][Medline]
- Davis CJ Jr, Barton JH, Sesterhenn IA, Mostofi FK. Metanephric
adenoma: clinicopathological study of fifty patients. Am J Surg
Pathol 1995; 19:1101
-1114[Medline]
- Fielding JR, Visweswaran A, Silverman SG, Granter SR, Renshaw AA.
CT and ultrasound features of metanephric adenoma in adults with pathologic
correlation. J Comput Assist Tomogr 1999;23
: 441-444[CrossRef][Medline]
- Lerut E, Roskams T, Joniau S, et al. Metanephric adenoma during
pregnancy: clinical presentation, histology, and cytogenetics. Hum
Pathol 2006; 37:1227
-1232[CrossRef][Medline]
- Araki T, Hata H, Asakawa E, Araki T. MRI of metanephric adenoma.
J Comput Assist Tomogr 1998;22
: 87-90[CrossRef][Medline]
- Patankar T, Punekar S, Madiwale C, Prasad S, Hanchate V.
Metanephric adenoma in a solitary kidney. Br J Radiol1999; 72:80
-81[Abstract]
- Prasad SR, Sahani DV, Mino-Kenudson M, et al. Neoplasms of the
perivascular epithelioid cell involving the abdomen and the pelvis:
cross-sectional imaging findings. J Comput Assist
Tomogr 2007; 31:688
-696[Medline]
- Martignoni G, Pea M, Rigaud G, et al. Renal angiomyolipoma with
epithelioid sarcomatous transformation and metastases: demonstration of the
same genetic defects in the primary and metastatic lesions. Am J
Surg Pathol 2000; 24:889
-894[CrossRef][Medline]
- Eble JN. Angiomyolipoma of kidney. Semin Diagn
Pathol 1998; 15:21
-40[Medline]
- Casper KA, Donnelly LF, Chen B, Bissler JJ. Tuberous sclerosis
complex: renal imaging findings. Radiology2002; 225:451
-456[Abstract/Free Full Text]
- Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda
K. Renal angiomyolipoma: relationships between tumor size, aneurysm formation,
and rupture. Radiology 2002;225
: 78-82[Abstract/Free Full Text]
- Siegel CL, Middleton WD, Teefey SA, McClennan BL. Angiomyolipoma
and renal cell carcinoma: US differentiation.
Radiology 1996;198
: 789-793[Abstract/Free Full Text]
- Helenon O, Merran S, Paraf F, et al. Unusual fatcontaining tumors
of the kidney: a diagnostic dilemma. RadioGraphics1997; 17:129
-144[Abstract]
- Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat:
differentiation from renal cell carcinoma at biphasic helical CT.
Radiology 2004;230
: 677-684[Abstract/Free Full Text]
- Kim JK, Kim SH, Jang YJ, et al. Renal angiomyolipoma with minimal
fat: differentiation from other neoplasms at double-echo chemical shift FLASH
MR imaging. Radiology 2006;239
: 174-180[Abstract/Free Full Text]
- Daneshmand S, Huffman JL. Endoscopic management of renal
hemangioma. J Urol 2002;167
: 488-489[CrossRef][Medline]
- Prasad SR, Humphrey PA, Menias CO, et al. Neoplasms of the renal
medulla: radiologic-pathologic correlation.
RadioGraphics 2005;25
: 369-380[Abstract/Free Full Text]
- Lee HS, Koh BH, Kim JW, et al. Radiologic findings of renal
hemangioma: report of three cases. Korean J Radiol2000; 1:60
-63[Medline]
- Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A. Renal
cystic diseases: a review. Adv Anat Pathol2006; 13:26
-56[CrossRef][Medline]
- Gupta R, Sharma R, Gamanagatti S, Dogra PN, Kumar A. Unilateral
renal lymphangiectasia: imaging appearance on sonography, CT and MRI.
Int Urol Nephrol 2007;39
: 361-364; epub 2006 Dec
14[CrossRef][Medline]
- Levine E. Lymphangioma presenting as a small renal mass during
childhood. Urol Radiol 1992;14
: 155-158[Medline]
- Lee SY, Hsu HH, Chang CT, Yang CW, Wong YC, Wang LJ. Renal capsular
leiomyoma: imaging features on computed tomography and angiography.
Nephrol Dial Transplant 2006;21
: 228-229[Free Full Text]
- Nagar AM, Raut AA, Narlawar RS, Bhatgadde VL, Rege S, Thapar V.
Giant renal capsular leiomyoma: study of two cases. Br J
Radiol 2004; 77:957
-958[Abstract/Free Full Text]
- Steiner M, Quinlan D, Goldman SM, et al. Leiomyoma of the kidney:
presentation of 4 new cases and the role of computerized tomography.
J Urol 1990; 143:994
-998[Medline]
- Inoue K, Tsukuda S, Kayano H, Tanaka J, Heshiki A. A case of
hypervascular renal capsule leiomyoma. Radiat Med2000; 18:323
-326[Medline]
- Martin SA, Mynderse LA, Lager DJ, Cheville JC. Juxtaglomerular cell
tumor: a clinicopathologic study of four cases and review of the literature.
Am J Clin Pathol 2001;116
: 854-863[Abstract/Free Full Text]
- Conn JW, Cohen EL, Lucas CP, et al. Primary reninism: hypertension,
hyperreninemia, and secondary aldosteronism due to renin-producing
juxtaglomerular cell tumors. Arch Intern Med1972; 130:682
-696[Abstract/Free Full Text]
- Dunnick NR, Hartman DS, Ford KK, Davis CJ Jr, Amis ES Jr. The
radiology of juxtaglomerular tumors. Radiology1983; 147:321
-326[Abstract/Free Full Text]
- Tanabe A, Naruse M, Ogawa T, et al. Dynamic computer tomography is
useful in the differential diagnosis of juxtaglomerular cell tumor and renal
cell carcinoma. Hypertens Res 2001;24
: 331-336[CrossRef][Medline]
- Lerman RJ, Pitcock JA, Stephenson P, Muirhead EE. Renomedullary
interstitial cell tumor (formerly fibroma of renal medulla). Hum
Pathol 1972; 3:559
-568[CrossRef][Medline]
- Antic T, Perry KT, Harrison K, et al. Mixed epithelial and stromal
tumor of the kidney and cystic nephroma share overlapping features:
reappraisal of 15 lesions. Arch Pathol Lab Med2006; 130:80
-85[Medline]
- Turbiner J, Amin MB, Humphrey PA, et al. Cystic nephroma and mixed
epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis
of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a
unifying term. Am J Surg Pathol 2007;31
: 489-500[CrossRef][Medline]
- Pawade J, Soosay GN, Delprado W, Parkinson MC, Rode J. Cystic
hamartoma of the renal pelvis. Am J Surg Pathol1993; 17:1169
-1175[CrossRef][Medline]
- Durham JR, Bostwick DG, Farrow GM, Ohorodnik JM. Mesoblastic
nephroma of adulthood: report of three cases. Am J Surg
Pathol 1993; 17:1029
-1038[Medline]
- Yoshida S, Nakagomi K, Goto S, Ozawa T. Cystic hamartoma of the
renal pelvis. Int J Urol 2004;11
: 653-655[CrossRef][Medline]
- Michal M, Syrucek M. Benign mixed epithelial and stromal tumor of
the kidney. Pathol Res Pract 1998;194
: 445-448[Medline]
- Michal M, Hes O, Bisceglia M, et al. Mixed epithelial and stromal
tumors of the kidney: a report of 22 cases. Virchows
Arch 2004; 445:359
-367[CrossRef][Medline]
- Adsay NV, Eble JN, Srigley JR, Jones EC, Grignon DJ. Mixed
epithelial and stromal tumor of the kidney. Am J Surg
Pathol 2000; 24:958
-970[CrossRef][Medline]
- Park HS, Kim SH, Kim SH, et al. Benign mixed epithelial and stromal
tumor of the kidney: imaging findings. J Comput Assist
Tomogr 2005; 29:786
-789[CrossRef][Medline]
- Svec A, Hes O, Michal M, Zachoval R. Malignant mixed epithelial and
stromal tumor of the kidney. Virchows Arch2001; 439:700
-702[Medline]
- Eble JN, Bonsib SM. Extensively cystic renal neoplasms: cystic
nephroma, cystic partially differentiated nephroblastoma, multilocular cystic
renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin
Diagn Pathol 1998; 15:2
-20[Medline]
- Kural AR, Obek C, Ozbay G, Onder AU. Multilocular cystic nephroma:
an unusual localization. Urology 1998;52
: 897-899[CrossRef][Medline]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. K. Sandstrom, J. Pugsley, and L. M. Mitsumori
Renal Angiomyolipoma With Nontraumatic Pulmonary Fat Embolus
Am. J. Roentgenol.,
June 1, 2009;
192(6):
W275 - W276.
[Full Text]
[PDF]
|
 |
|